needed immunize person order 20 million conventional doses actually yield h5n1 vaccine 3.3 million people true number lower h5 strains grow poorly eggs batch yields active antigen usual grim picture brighten niaid analyzes final results trial possible extend vaccine supplies use adjuvants substances added vaccines increase immune response induce new immunization approaches injecting vaccine skin muscle caching large amounts prepandemic vaccine not impossible clearly challenge vaccines expire years current production rates stockpile never grow 228 million doses needed cover highest priority groups let roughly 600 million doses needed vaccinate u.s. nations face similar limitations primary reason capacity tight matthews explains